CNS Spectr. 2022 Jul 29:1-3. doi: 10.1017/S109285292200092X. Online ahead of print.
ABSTRACT
With the exponential growth in investment attention to brain health-solutions spanning brain wellness to mental health to neurological disorders-tech giants, payers, and biotechnology companies have been making forays into this field to identify technology solutions and pharmaceutical amplifiers. So far, their investments have had mixed results. The concept of open innovation (OI) was first coined by Henry Chesbrough to describe the paradigm by which enterprises allow free flow of ideas, products, and services from the outside to the inside and vice versa in order to remain competitive, particularly in rapidly evolving fields where there is abundant, relevant knowledge outside the traditional walls of the enterprise. In this article, we advocate for further exploration and advancement of OI in brain health.
PMID:35904045 | PMC:PMC9906564 | DOI:10.1017/S109285292200092X
Authors
Harris Eyre
Neuroscientist
Erin Smith
Creative technologist
